Laurie Villanueva

Laurie Villanueva has been writing about consumer issues for over two decades, Her work for largely focuses on pharmaceutical and medical device safety, including the ongoing litigation surrounding Risperdal, proton pump inhibitors, Invokana, Levaquin, defective hip implants, the Bair Hugger forced air warming blanket, and IVC filters. Laurie has also devoted a great deal of coverage to women’s health issues, especially recent litigation involving talcum powder, power morcellators, transvaginal mesh, and breast implants.

Laurie graduated from Penn State University in 1990 with a degree in journalism. After spending many years covering local government for various print media outlets, she is now focused on utilizing the internet to raise awareness about important consumer issues.

Risperdal Gynecomastia Plaintiff Wins New Trial on Appeal

The Superior Court of Pennsylvania has reinstated a Risperdal lawsuit that was dismissed in 2016, following just 11 days of testimony in the Philadelphia Court of Common Pleas. Risperdal Lawsuit Background Plaintiff Tommy Moroni of Texas was prescribed Risperdal in … Continue reading

Federal Judge Cuts Roundup Cancer Verdict, Agrees Monsanto Deserves Punishment

An $80 million verdict recently awarded to man who claimed Roundup herbicide caused his cancer was reduced to $55 million earlier this week, even though a federal judge in California agreed that Monsanto “deserved to be punished” for its “reprehensible … Continue reading

Bayer Loses Bid for New Trial in $80 Million Roundup Lawsuit

Bayer AG won’t be getting a do-over in the case of a California man who developed non-Hodgkin’s lymphoma following years of exposure to Monsanto Roundup. The company had sought a new trial in a bid to reverse the $80 million … Continue reading

California Appeals Court Says Talcum Powder Lawsuit Plaintiff Deserves New Trial

The family of a California woman who died of ovarian cancer following decades of talcum powder use will have another chance for compensation, after an appeals court overturned part of a decision to dismiss her entire $417 million verdict. According … Continue reading

Gadolinium Deposits Shown to Accumulate in Brains of Early MS Patients

Researchers at the University of Buffalo have shown that gadolinium MRI contrast dyes can accumulate in the brain when administered to patients in the early stages of multiple sclerosis, or MS. While the gadolinium deposits did not appear to correlate … Continue reading

Takeda Faces New Uloric Heart Attack Lawsuit

Mark Gomez suffered a heart attack roughly two years after he began taking Uloric, Takeda Pharmaceutical’s controversial gout drug. According to a Uloric lawsuit recently filed on his behalf in the U.S. District Court, Northern District of Illinois, adequate safety … Continue reading

Parties in 3M Combat Arms Earplugs Lawsuits Push for Single-Track Litigation

Lawyers representing plaintiffs and defendants in hundreds of lawsuits involving the 3M Company’s Combat Arms Earplugs, Version 2, are urging a federal judge to allow individual personal injury claims and class action complaints to proceed on a single litigation track. … Continue reading

Monsanto Roundup Juror Defends $80 Million Glyphosate Cancer Verdict

A member of the jury that awarded $80 million to a California man who blamed Monsanto Roundup for his cancer has come forward to defend the panel’s decision. Glyphosate Cancer Verdict Included $75 Million in Punitive Damages Plaintiff Edward Hardeman, 77, … Continue reading

Gilead’s Truvada Donation Raises Suspicions of Patent Ploy

Gilead Sciences recently made news by promising to donate 2.5 million of bottles Truvada, one of the company’s blockbuster TDF-based HIV medications, to government efforts aimed at eradicating HIV and AIDS. While the Truvada donation would improve access among those … Continue reading

Aurobindo Hit with FDA Warning Letter After Valsartan Recalls

Aurobindo Pharmaceuticals, one of multiple generic drug makers to announce valsartan recalls over the past year, has received a Warning Letter from the U.S. Food & Drug Administration (FDA) for repeated violations at three plants in India. FDA Faults Aurobindo … Continue reading

Follow Us on Google+ on Facebook on LinkedIn on Twitter on YouTube on Pinterest